To compare postoperative analgesia by adding additive intrathecal buprenorphine to 0.75% hyperbaric ropivacaine in lower segmental caesarean section.
Phase 4
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2023/06/053571
- Lead Sponsor
- Rajarajeswari medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA I to II Patients Female patients.2. Aged between 20 to 60 years.3. Normal liver and renal function test, Coagulation profile.4. Undergoing Lower Segment Caesarean Section Surgery.
Exclusion Criteria
1. Patients with history of allergy to local anaesthetics.2. Patients with history of mental disorders.3. Patient Refusal.4. Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders.5. Infection at site of procedure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The post operative analgesic efficacy of intrathecal/ subarachnoid buprenorphine with 0.75% hyperbaric Ropivacaine is better than intrathecal/ subarachnoid 0.75% hyperbaric Ropivacaine in lower segment caesarian sectionsTimepoint: VAS score in post operative period at 1 hour , 2 hour , 4 hours , 8 hours , 12 hours and 24 hours post surgery
- Secondary Outcome Measures
Name Time Method To assess the following characteristics. <br/ ><br>1. Sensory and motor blockade. <br/ ><br>2. Effective analgesic time. <br/ ><br>3. Hemodynamics. <br/ ><br>4. Complication rates. <br/ ><br>5. Post operative analgesia using Visual Analog Scale [ VAS] <br/ ><br>Timepoint: Intraoperative and postoperative period 24 hrs post surgery